l-insulin to erythrocyte receptors increased linearly with reticulocyte count in routine blood specimens from hospitalized patients. Specific binding as high as 30-35% is observed in patients with reticulocyte counts in the range of 20-25% compared with 9.0 ± 0.5% specific binding in healthy control subjects with normal reticulocyte counts. It is concluded that care must be exercised in interpreting elevations of specific T here have been a number of recent studies describing changes in insulin binding to human erythrocyte receptors in disease states, including diabetes 1 and anorexia nervosa. 2 In view of a report by Thomopoulos et al. 3 that rabbit reticulocytes have 10-fold greater insulin binding sites than mature rabbit red blood cells, we thought it important to determine the influence of the age of human erythrocytes on insulin binding. The reticulocyte count is one index of erythrocyte age. In this report we determined the variation in insulin binding to erythrocytes in the blood of normal subjects and of hospitalized patients with normal or elevated reticulocyte counts.
MATERIALS AND METHODS
Blood for insulin binding study was obtained from specimens sent to the hematology laboratory for reticulocyte counts or from normal volunteers. Plasma from the bloods was saved for insulin assay. Monoiodinated 125 l-insulin was prepared as previously published. 4 Erythrocytes were prepared according to the procedure described by Gambhir et al. 5 with the following modifications. At each step of preparation, white blood cells were carefully aspirated while avoiding excessive removal of the upper layer of erythrocytes. On completion of preparation, erythrocytes were suspended to a concentration of 4.4 x 10 9 cells/ml and a reticulocyte count was done. Loss of reticulocytes during the preparation procedure ranged from 10 to 50%. Leukocyte contamination was less than 10 5 /ml. 125 l-insulin binding to erythrocytes was determined by incubating 0.3 ml of the cell suspension with 50 pg of 125 l-insulin and varying concentrations of unlabeled insulin in a final volume of 0.5 ml. After overnight incubation at 4°C, 0.2 ml portions were placed into chilled test tubes and washed with 2.5 ml cold normal saline. The tubes were quickly vortexed and centrifuged at 2000 x g at 4°C for 5 min, after which the supernatant was aspirated and the cell pellet counted.
125 l-insulin binding in the presence of 10 5 ng/ml of unlabeled insulin was taken to be nonspecific binding and accounted for 2-4% of total radioactivity added. In one experiment, a portion of an erythrocyte suspension was taken for assay of insulin binding and the remainder of the suspension was centrifuged at 400 x g for 20 min. The top and bottom quarter portions of the sedimented cells were resuspended and also assayed for insulin binding. In all cases the percentage is expressed in terms of 125 l-insulin binding to 2.64 x 10 9 erythrocytes/ml incubation volume.
RESULTS
A plot of erythrocyte insulin binding as a function of reticulocyte count for each patient studied is shown in Figure 1 . The high correlation is obvious, and regression analysis of the data gives a correlation coefficient of 0.87. Individual competitive binding curves were analyzed for most of the blood samples, and in all cases the half-maximal binding of labeled insulin to erythrocytes occurred in the presence of 4 -5 ng/ml unlabeled insulin. The Scatchard plots were essentially parallel. Taken together, these data suggest that the differences in binding are due, at least in part, to a greater number of binding sites on human reticulocytes than on mature erythrocytes.
The illnesses which produced the reticulocytosis were blood loss, hemolysis from various causes, and pernicious anemia during cyanocobalamin therapy. Although erythrocyte mean cell volumes tended to be higher than normal in bloods with elevated reticulocyte counts, quite often the mean cell volumes were normal-especially when hemolysis was the cause of reticulocytosis. Specific 125 l-insulin binding to erythrocytes from nine normal laboratory controls ranged from 6.2 to 11.6% with an average of 9.0 ± 0.5%. Insulin binding was not related to plasma insulin levels in the bloods studied.
A patient with pernicious anemia was followed during the course of treatment with cyanocobalamin (Table 1) . It is evident that insulin binding to his erythrocytes remained elevated despite a decrease in the percentage of reticulocytes from 21.4% at 6 days to 2.1 % at 20 days. These data suggest that early mature erythrocytes, like reticulocytes, also have an increased number of insulin receptors per cell. Since erythrocytes are thought to form an age-related gradient on centrifugation, with younger cells sedimenting on top and older cells on the bottom, 6 we determined the insulin binding to various centrifuged erythrocyte fractions. Insulin binding to an erythrocyte preparation with a modestly elevated reticulocyte count was compared with suspensions of erythrocytes taken from the top and bottom quarters of the same preparation after it had been centrifuged at 400 x g for 20 min ( Table 2 ). The data suggest that even a relatively low centrifugal force can separate erythrocytes into at least two populations of cells. The top portion contains erythrocytes with a larger cell size and higher insulin binding. Erythrocytes from the bottom portion have smaller cell size and lower insulin binding.
DISCUSSION
These data demonstrate that, in man, not only reticulocytes but also early mature erythrocytes have more insulin binding sites per cell than older erythrocytes. As a result in some hospitalized patients, even those whose reticulocytes appeared to be in the normal range, manifest erythrocyte insulin binding increased above the levels found in healthy control subjects. (This was most evident in the case of the cyanocobalamin-treated pernicious anemia patient whose insulin binding, even after the reticulocyte count had returned to 2%, remained elevated to three times the mean value for normals.) Since a variety of disease states may alter erythrocyte survival, the mean circulating erythrocyte age in patients with these diseases may be significantly less than in normal subjects. Thus, in the absence of a simple method capable of measuring differences in mean cell age between erythrocytes from normal and disease populations, we must rely on a clinical history to determine if the mean cell age of the patient is likely to be younger than that of the control group. Care must therefore be exercised in interpreting elevations of insulin binding to erythrocytes, as due to specific disease processes, without considering how the disease itself may affect mean erythrocyte age at the time of the sampling.
